Sylvia Hartmann
Overview
Explore the profile of Sylvia Hartmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
3324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kurz K, Steinlein S, Kreuz M, Ziepert M, Staiger A, Barth T, et al.
Hemasphere
. 2025 Mar;
9(3):e70093.
PMID: 40060117
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma. Despite a high cure rate, too many patients show refractory (ref) or relapsed (rel) disease. This study examines the...
2.
Geib K, Scharf S, Schafer H, Hartmann S, Hansmann M, Wurzel P
Acta Histochem
. 2025 Jan;
127(1):152232.
PMID: 39883976
Follicular lymphoma (FL) represents the most prevalent subtype of non-Hodgkin's-lymphoma in Western Europe and the United States. While the examination of two-dimensional histological slides remains the gold standard method for...
3.
Hansmann M, Scharf S, Wurzel P, Hartmann S
Hum Pathol
. 2024 Nov;
156:105699.
PMID: 39603364
The cellular compartments in the lymph node form dynamic networks, enabling coordinated innate and adaptive immunological responses. This compartmentalization of the lymph node into subcompartments, such as the T and...
4.
Minciacchi V, Bravo J, Karantanou C, Pereira R, Zanetti C, Kumar R, et al.
Nat Commun
. 2024 Nov;
15(1):10059.
PMID: 39567540
Fibrinolysis influences the mobilization of hematopoietic stem cells from their bone marrow microenvironment (BMM). Here we show that activation of plasmin, a key fibrinolytic agent, by annexin A2 (ANXA2) distinctly...
5.
Hartmann S
Pathologie (Heidelb)
. 2024 Nov;
45(Suppl 1):103-104.
PMID: 39557699
No abstract available.
6.
Sherif M, Schafer H, Scharf S, van Oostendorp V, Sadeghi Shoreh Deli A, Loth A, et al.
Br J Haematol
. 2024 Oct;
205(6):2327-2337.
PMID: 39355919
Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent aggressive B-cell lymphoma. The group is heterogeneous and the outcome is variable. A variety of approaches have been employed with the...
7.
Minciacchi V, Karantanou C, Bravo J, Pereira R, Zanetti C, Krack T, et al.
Blood Adv
. 2024 Jul;
8(19):4983-4996.
PMID: 38996202
Inflammation promotes solid tumor progression, but how regulatory mechanisms of inflammation may affect leukemia is less well studied. Using annexin A5 (ANXA5), a calcium-binding protein known for apoptosis, which we...
8.
Gretser S, Sadeghi Shoreh Deli A, Loth A, Wild P, Gradhand E, Hartmann S
Mod Pathol
. 2024 Jul;
37(9):100559.
PMID: 38969271
Fluorescence confocal microscopy (FCM) is an optical technique that uses laser light sources of different wavelengths to generate real-time images of fresh, unfixed tissue specimens. Unlike conventional histologic evaluation methods,...
9.
Yadigaroglu K, Scharf S, Gretser S, Schafer H, Sadeghi Shoreh Deli A, Loth A, et al.
Haematologica
. 2024 May;
109(10):3295-3304.
PMID: 38779721
Although checkpoint molecules like CTLA-4 and PD1 have been described several years ago, checkpoint inhibitors such as nivolumab (an anti-PD-1 antibody) have only recently been used to treat classic Hodgkin...
10.
Hartmann S, Rudelius M
Dtsch Med Wochenschr
. 2024 May;
149(11):613-620.
PMID: 38749437
An internationally uniform lymphoma classification is of fundamental importance for the comparability of clinical studies. There are currently 2 parallel classifications: the "International Consensus Classification" and the WHO-classification. Follicular lymphoma...